Dayno Jeffrey M. — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Dayno Jeffrey M. is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Profile
Jeffrey M. Dayno is the President and Chief Executive Officer of Harmony Biosciences Holdings, Inc. (HRMY), a commercial-stage pharmaceutical company focused on therapies for rare neurological diseases, including WAKIX (pitolisant) for narcolepsy. According to the most recent SEC filing dated January 26, 2026, Dayno holds the roles of President and CEO at Harmony, indicating his position as the company’s top executive and primary leader.
Role
Insider
Notability
60/100
Board memberships
Harmony Biosciences Holdings, Inc.
Awards & honors
Leading Harmony Biosciences as CEO and President
Overseeing the commercialization strategy for WAKIX (pitolisant) and growth initiatives in rare neurological diseases
Jeffrey M. Dayno is the President and Chief Executive Officer of Harmony Biosciences Holdings, Inc. (HRMY), a commercial-stage pharmaceutical company focused on therapies for rare neurological diseases, including WAKIX (pitolisant) for narcolepsy. According to the most recent SEC filing dated January 26, 2026, Dayno holds the roles of President and CEO at Harmony, indicating hi…
Where can I see all of Dayno Jeffrey M.'s SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
